Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Synthesis of Phosphatidylcholine in the ER Membrane01:27

Synthesis of Phosphatidylcholine in the ER Membrane

The ER synthesizes lipids for building cell membranes and performing cellular functions such as energy storage and signaling. The lipid synthesis machinery embedded in the ER membrane primarily collects all reactants from the cytosol. Following synthesis, the secretory pathway and the ER contact sites distribute these lipids to other cellular organelles. Additionally, the energy-rich triacylglycerides are transported from the ER via lipid droplets.
The major components of all eukaryotic cell...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Generation of Infectious Prions Amenable to Site-Specific Click Chemistry.

ACS chemical biology·2026
Same author

Fluorescent non-canonical amino acid as a site-specific conformational probe of prion formation.

bioRxiv : the preprint server for biology·2026
Same author

Generation of Infectious Prions Amenable to Site-specific Click Chemistry.

bioRxiv : the preprint server for biology·2026
Same author

Mutant knock-in mice display enhanced susceptibility to pure prion protein fibrils.

The Journal of general virology·2026
Same author

Genome-wide screens identify core regulators of cell surface prion protein expression.

Scientific reports·2026
Same author

Oligosaccharyltransferase (OST) complex inhibition effectively treats rodent and human prions.

PLoS pathogens·2026

Related Experiment Video

Updated: May 19, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
12:57

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

Published on: January 8, 2015

Phosphatidylethanolamine as a prion cofactor: potential implications for disease pathogenesis.

Surachai Supattapone1

  • 1Department of Biochemistry, Geisel School of Medicine, Dartmouth College, Hanover, NH, USA. supattapone@dartmouth.edu

Prion
|August 17, 2012
PubMed
Summary

Mammalian prions require cofactors for in vitro formation. Phosphatidylethanolamine (PE) is identified as an essential cofactor, potentially linking prion formation to neurodegeneration.

More Related Videos

High-throughput Screening for Protein-based Inheritance in S. cerevisiae
08:12

High-throughput Screening for Protein-based Inheritance in S. cerevisiae

Published on: August 8, 2017

Monitoring Cell-to-cell Transmission of Prion-like Protein Aggregates in Drosophila Melanogaster
10:26

Monitoring Cell-to-cell Transmission of Prion-like Protein Aggregates in Drosophila Melanogaster

Published on: March 12, 2018

Related Experiment Videos

Last Updated: May 19, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
12:57

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

Published on: January 8, 2015

High-throughput Screening for Protein-based Inheritance in S. cerevisiae
08:12

High-throughput Screening for Protein-based Inheritance in S. cerevisiae

Published on: August 8, 2017

Monitoring Cell-to-cell Transmission of Prion-like Protein Aggregates in Drosophila Melanogaster
10:26

Monitoring Cell-to-cell Transmission of Prion-like Protein Aggregates in Drosophila Melanogaster

Published on: March 12, 2018

Area of Science:

  • Neuroscience
  • Biochemistry
  • Molecular Biology

Background:

  • Mammalian prions are infectious agents implicated in neurodegenerative diseases.
  • Prion protein (PrP) alone cannot form infectious prions in vitro.
  • Cofactor molecules are necessary for in vitro prion formation.

Purpose of the Study:

  • To discuss the role of essential cofactor molecules in prion propagation.
  • To explore phosphatidylethanolamine (PE) as an endogenous cofactor for prion formation.
  • To investigate the link between cofactors, prion formation, and neurodegeneration.

Main Methods:

  • In vitro prion formation assays.
  • Isolation and identification of endogenous cofactor molecules.
  • Discussion of molecular mechanisms.

Main Results:

  • Phosphatidylethanolamine (PE) was identified as an essential endogenous cofactor for prion propagation in vitro.
  • Prion formation in vitro requires both prion protein (PrP) and specific cofactors.

Conclusions:

  • Phosphatidylethanolamine (PE) is crucial for in vitro prion formation.
  • Cofactor molecules may serve as a molecular link between prion formation and neurodegeneration.
  • Further research is needed to elucidate the precise role of PE in prion diseases.